Erich Pawelka - Infectious Diseases

Author Information

Erich Pawelka is affiliated with the Department for Infectious Diseases at Kaiser-Franz-Josef-Hospital (KFJ), located in Vienna, Austria. His research is primarily centered on infectious diseases, with a particular focus on COVID-19, as evidenced by his numerous publications in this area. His work contributes to the understanding and management of infectious diseases, with a specific emphasis on COVID-19-related complications and patient outcomes.

Research Contributions

Erich Pawelka has been actively involved in research related to COVID-19, exploring various facets of the disease including diagnostic testing, thrombotic complications, and comparative analyses with influenza. His publications reflect a commitment to advancing clinical practice through the evaluation of diagnostic tools, the development of predictive models for patient outcomes, and the examination of comorbidities in COVID-19 patients. Notably, his work also investigates the cellular responses in COVID-19 patients and the management of respiratory infections in critical care settings.

Aliases

Erich Pawelka is also known by the aliases E Pawelka and E. Pawelka. These variations of his name may appear in different publications and databases.

Publication and Citation Metrics

Metric	Value
Total Citation Count	1095
H-Index	15
Total Paper Count	50

Publications:

Evaluation of Five Commercial SARS-CoV-2 Antigen Tests in a Clinical Setting

DOI: 10.1007/s11606-022-07448-x

Year: 2022

Pulmonary embolism and acute psychosis, a case report of an outpatient with a mild course of COVID-19

DOI: 10.21203/RS.3.RS-259902/V1

Year: 2021

A Model Predicting Mortality of Hospitalized Covid-19 Patients Four Days After Admission: Development, Internal and Temporal-External Validation

DOI: 10.3389/fcimb.2021.795026

Year: 2021

Platelets and Antiplatelet Medication in COVID-19-Related Thrombotic Complications

DOI: 10.3389/fcvm.2021.802566

Year: 2021

COVID-19 In-Hospital Mortality in People with Diabetes Is Driven by Comorbidities and Age—Propensity Score-Matched Analysis of Austrian National Public Health Institute Data

DOI: 10.3390/v13122401

Year: 2021

Platelet Phenotype Analysis of COVID-19 Patients Reveals Progressive Changes in the Activation of Integrin αIIbβ3, F13A1, the SARS-CoV-2 Target EIF4A1 and Annexin A5

DOI: 10.3389/fcvm.2021.779073

Year: 2021

Management of hospitalized influenza A patients during the season 2018/19

DOI: 10.1007/s00508-021-01950-8

Year: 2021

COVID-19 is not “just another flu”: a real-life comparison of severe COVID-19 and influenza in hospitalized patients in Vienna, Austria

DOI: 10.1007/s15010-021-01610-z

Year: 2021

Clinical and Angiographic Features in Three COVID-19 Patients with Takotsubo Cardiomyopathy. Case Report

DOI: 10.1007/s42399-020-00683-5

Year: 2021

Detection of bacteria via multiplex PCR in respiratory samples of critically ill COVID-19 patients with suspected HAP/VAP in the ICU

DOI: 10.1007/s00508-021-01990-0

Year: 2021

What is the Global Impact of Dengue?

What are Direct Acting Antivirals (DAAs)?

Are condoms effective against all STIs?

How Can Individuals and Communities Help in WHO’s Efforts?

What is the Future of Genomic and Proteomic Studies in Infectious Diseases?

What is a Biopsy?

What Types of Surveillance Systems Exist?

What is COVID-19?

Who Should Receive Antiviral Treatment?

What Are Some of WHO’s Recent Initiatives in Infectious Disease Control?

Partnered Content Networks

Relevant Topics